1. E‐Cadherin restricts mast cell degranulation in mice
- Author
-
Nadine Kiessling, Gregor Jessberger, Axel Roers, Rolf Jessberger, Ljubica Bakic, Thomas Müller-Reichert, Theres Klewer, and Robert Kiewisz
- Subjects
Inflammation ,biology ,Receptors, IgE ,Cadherin ,Cell adhesion molecule ,Immunology ,Degranulation ,Mice, Transgenic ,Biological activity ,Immunoglobulin E ,Cadherins ,Cell Degranulation ,In vitro ,Proinflammatory cytokine ,Cell biology ,Mice ,In vivo ,biology.protein ,Animals ,Cytokines ,Immunology and Allergy ,Mast Cells - Abstract
Crosslinking of FceRI-bound IgE triggers the release of a large number of biologically active, potentially anaphylactic compounds by mast cells. FceRI activation ought to be well-controlled to restrict adverse activation. As mast cells are embedded in tissues, adhesion molecules may contribute to limiting premature activation. Here, we report that E-Cadherin serves that purpose. Having confirmed that cultured mast cells express E-Cadherin, a mast-cell-specific E-Cadherin deficiency, Mcpt5-Cre E-Cdhfl/fl mice, was used to analyze mast cell degranulation in vitro and in vivo. Cultured peritoneal mast cells from Mcpt5-Cre E-Cdhfl/fl mice were normal with respect to many parameters but showed much-enhanced degranulation in three independent assays. Soluble E-Cadherin reduced the degranulation of control cells. The release of some newly synthesized inflammatory cytokines was decreased by E-Cadherin deficiency. Compared to controls, Mcpt5-Cre E-Cdhfl/fl mice reacted much stronger to IgE-dependent stimuli, developing anaphylactic shock. We suggest E-Cadherin-mediated tissue interactions restrict mast cell degranulation to prevent their precocious activation.
- Published
- 2021